PROFHILO® family of products are unfunded medical devices product and treatment costs apply. PROFHILO® family of products are Class III medical devices containing 16mg high molecular weight (MW) hyaluronic acid (HA) + 16mg low MW HA/1mL syringe for its use in the face and body, where it is injected with an ultrafine needle to plump the skin to smooth away wrinkles and improve texture and skin quality. PROFHILO® must only be administered by a medical practitioner or a qualified nurse injector (who operates under the supervision of a medical practitioner). PROFHILO® has risks and benefits. Talk to your healthcare professional about the benefits/risks of this procedure or if you have concerns or side effects. Always follow the instructions you are given. For further product information, please refer to your medical practitioner or the Instructions for Use leaflet at Dermocosmètica PTY LTD, Australia. PROFHILO® is a registered trademark of IBSA Accelagen Pty. Ltd. Whanganui.
BELOTERO® is an unfunded medical device, product and treatment costs apply. Belotero is hyaluronic acid dermal filler. It is used to improve the look of facial folds, wrinkles and restore volume, including contouring, shaping and volumising of the lips, or to treat early-signs of photodamaged skin. Always read the label and consult your Healthcare Professional for more information. This medical device must be administered by a Healthcare Professional. You should tell your practitioner and avoid treatment with Belotero® if you: have had an allergic reaction to any of the ingredients; if you tend to develop keloids or heavy scars; have any bleeding disorders, poor wound healing, inflamed or infected skin, active auto-immune disease or general infection; are under the age of 18; are pregnant or breastfeeding. Please inform your practitioner of any diseases you have or have had. These include in particular cardiovascular diseases, autoimmune diseases, diabetes, epilepsy, liver or kidney problems, skin infections or severe allergies. If you take medication or vitamins, have had previous cosmetic procedures, or have been treated with other implants, please inform your practitioner. Copyright © 2024. Pharmacy Retailing NZ Limited t/a Health Care Logistics (HCL) 58 Richard Pearse Drive, Mangere, Auckland 2022. All rights reserved. Belotero® and Merz Aesthetics are registered trademarks of Merz Pharma GMbH & Co. KGaA.
ASK YOUR HEALTH CARE PROFESSIONAL IF JUVEDERM® IS RIGHT FOR YOU. JUVEDERM® family of products are unfunded medical devices, product and treatment costs apply.JUVÉDERM® family of products are class III medical devices and must be administered by a healthcare professional. The JUVÉDERM® range of products is a smooth, clear, colourless gel that contains hyaluronic acid to help correct or enhance facial contours; to define, correct or enhance lips; or improve the tone, texture and hydration of the skin. It also contains lidocaine (local anaesthetic) which helps improve comfort to the patient during injection. JUVÉDERM® has risks and benefits. Talk to your healthcare professional about the benefits/risks of this procedure or if you have concerns or side effects. Always follow the instructions you are given. For more information, please read the Patient Information Leaflets available on request from Allergan Aesthetics by phoning 0800 659 912 or from allerganaesthetics.com.au/products. JUVÉDERM® VOLBELLA® VOLIFT® VOLITE™ VOLUMA® and VOLUX™ are registered trademarks and trademarks of Allergan an Abbvie Company.
ASK YOUR HEALTH CARE PROFESSIONAL IF TEOSYAL® IS RIGHT FOR YOU. TEOSYAL RHA® 1, TEOSYAL RHA® 2, TEOSYAL RHA® 3, TEOSYAL RHA® 4, TEOSYAL® PURESENSE REDENSITY 1, TEOSYAL® PURESENSE REDENSITY 2, TEOSYAL PURESENSE KISS ®, and TEOSYAL® PURESENSE ULTRA DEEP are trademark of the firm TEOXANE SA. These products are gel that contains hyaluronic acid, and 0.3% by weight of lidocaine hydrochloride (local anesthetic can induce a positive reaction to anti-doping tests). In the case of known hypersensitivity to lidocaine and/or amide local anaesthetic agents, we recommend not use lidocaine-containing products and please refer to products without lidocaine. They are class III medical device and are regulated health product bearing the CE marking (CE2797) under this regulation.Local manifestations: inflammatory reactions (erythema, oedema, pain at the point of injection), haematomas, itching, temporary loss of sensitivity around the injected area, dyschromia, abscesses, indurations, nodules (possibly granulomas).General manifestations: immediate hypersensitivity up to anaphylactic shock, migration of the implant.Rare but serious adverse events associated with the intravascular injection of soft tissue fillers in the face have been reported and include temporary or permanent vision impairment or blindness, skin necrosis and stroke.Please consult your physician or pharmacist for more information.Please refer to instructions for use. About Face Auckland New Zealand
Images are model shots - Not actual patients.
TAPS No: BG4363 - Oct 24